FABP4 Antikörper (N-Term)

Produktnummer ABIN336086

Dieses Anti-FABP4-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von FABP4 in WB und EIA. Geeignet für Human und Maus.

Kurzübersicht für FABP4 Antikörper (N-Term) (ABIN336086)

Target: FABP4 (Fatty Acid Binding Protein 4, Adipocyte (FABP4))

Reaktivität: Human, Maus

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser FABP4 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA)

Klon: 3F4

Produktdetails anti-FABP4 Antikörper

Bindungsspezifität: AA 1-132, N-Term

Spezifität: The antibody recognizes human and mouse FABP4. Other species not tested.

Produktmerkmale: Synonyms: A-FABP, Adipocyte lipid-binding protein, Fatty acid-binding protein 4

Aufreinigung: Protein-G affinity chromatography

Immunogen: Recombinant human FABP4 (1-132 aa) purified from E. coli

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA. Western blot (1: 500 - 2,000).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.0 mg/mL

Buffer: PBS, pH 7.4, containing 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for up to two weeks or (in aliquots) at -20 °C forlonger. Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Haltbarkeit: 12 months

Details zu FABP4

Target: FABP4 (Fatty Acid Binding Protein 4, Adipocyte (FABP4))

Andere Bezeichnung: FABP4

Hintergrund: FABP4 (Fatty acid binding protein 4) is expressed in adipocytes and macrophages, and integrates inflammatory and metabolic responses. FABP4 is thought to regulate fatty acid uptake, release, and storage in adipocytes and participates in systemic glucose homeostasis and in macrophage responses in atherosclerosis. Blocking this protein either through genetic engineering or drugs has the possibility of treating heart disease, diabetes, asthma, obesity, and fatty liver disease.Synonyms: A-FABP, Adipocyte lipid-binding protein, Fatty acid-binding protein 4

Gen-ID: 2167

UniProt: P15090

Pathways: Brown Fat Cell Differentiation